Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2295 SEK | +20.54% | +11.68% | -97.70% |
02:43pm | Xbrane Biopharma, Stada Sign US Licensing Deal for Lucentis Biosimilar | MT |
05-02 | Xbrane Biopharma AB Appoints Kristoffer Bissessar Was Elected as New Director | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 0.2600 | 1.568 | 2.255 |
Spread/Res. | -11.73% | -85.36% | -89.82% |
Spread/Supp. | +49.03% | +617.19% | +614.95% |
Support | 0.1540 | 0.0320 | 0.0321 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- XBRANE Stock
- Charts Xbrane Biopharma AB